DROGHEDA, IRELAND (December 8, 2021) – BD (Becton Dickinson and Company), a leading global medical technology company, held a ribbon cutting ceremony today to announce the creation of 100 new jobs at its Drogheda facility on Donore Road. These jobs are part of a $70 million (€62million) investment in the site to upgrade equipment and expand the company’s production of BD PosiFlush™ syringes.
The new 30,000-square-foot facility started production in September and 50 of the 100 new jobs have been filled. The remaining positions will be filled throughout 2022 and 2023 as the expansion of the facility continues. Key career opportunities include engineering, production, machine operations, logistics, management and administration. Open roles can be found at: https://emea.jobs.bd.com/location-ireland.
Mr Liam Dillon, BD Medical Site Director in Drogheda, said the company’s ongoing investment in the Drogheda facility reflects BD’s commitment to manufacturing excellence and supply capacity, along with its dedication to its employees and the local Drogheda community.
“We currently employ over 240 associates at the plant. Many are the second generation of family members joining the company. We see this expansion as a commitment to the people who work here and to the local economy in Drogheda and surrounding areas,” said Dillon. “We look forward to further building on our strong team in Drogheda to meet our customers’ needs and also help BD achieve its purpose of advancing the world of health by supplying critical devices that support vascular care and maintenance practices.”
The investment is supported by the Department of Jobs Enterprise and Innovation through the Industrial Development Agency (IDA) Ireland. Liam thanked the IDA for their support over the years. An Tánaiste, Leo Varadkar TD also attended the event and acknowledged how these new jobs will continue to contribute to the local community.
“I’m really happy to be in Drogheda today with BD, to announce this incredible expansion, which will be a real boost for the local community. €62million is being invested, with help from the Government through the IDA,” said Varadkar. “100 new jobs are being created and the fact that half of the posts have already been filled is a testament to the rich talent pool that is available in Drogheda. I wish the team the very best of luck with their growth plans.”
Since BD started production on Donore Road in 1964, thousands of local people have been employed at the facility and billions of syringes and medical devices have been produced. The company has continually invested in technology, innovation and training. Over the past five years BD has invested over $150 million in its manufacturing plant in Drogheda.
“Today’s announcement by BD is welcome news for the North East region. BD is a significant employer across Ireland where it has four sites, including here in Drogheda where it has been in operation for almost 60 years,” said CEO of IDA Ireland Martin Shanaha. “This exemplifies IDA Ireland’s continued commitment to winning jobs and investment in regional locations. I wish to congratulate BD on today’s announcement and acknowledge the substantial contribution the company has made to the Irish economy.”
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.